🇺🇸 FDA
Patent

US 12414968

Compositions comprising bacterially derived minicells and methods of using the same

granted A61KA61K31/337A61K31/4745

Quick answer

US patent 12414968 (Compositions comprising bacterially derived minicells and methods of using the same) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
EnGeneIC Molecular Delivery Pty Ltd
Grant date
Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/337, A61K31/4745, A61K31/505, A61K31/517